A frontline defense against neurodegenerative diseases:the development of early disease detection methods

Expert Rev Mol Diagn. 2019 Jul;19(7):559-563. doi: 10.1080/14737159.2019.1627202. Epub 2019 Jun 10.

Filippo Baldacci^{1

2

3

4}, Simone Lista^{2

3

4}, Andrea Vergallo^{2

3

4}, Giovanni Palermo¹, Filippo Sean Giorgi¹, Harald Hampel²

¹ a Department of Clinical and Experimental Medicine , University of Pisa , Pisa , Italy.
² b Sorbonne University, GRC n° 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital , Paris , France.
³ c Brain & Spine Institute (ICM) , INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital , Paris , France.
⁴ d Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology , Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital , Paris , France.

No abstract available

Keywords: Alzheimer; Parkinson; amyotrophic lateral sclerosis; blood biomarkers; dementia; neurofilament light chain; precision medicine.

Publication types